SCHEMBL3399676

SCHEMBL3399676

c1cc(CN2CCNCC2)ncc1NNc1ccc(CN2CCOCC2)nc1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 2/20 0.47
EPAS1 Q99814 2/20 0.47
HRH3 Q9Y5N1 3/20 0.46
CXCR4 P61073 3/20 0.44
MAPK7 Q13164 1/20 0.42
PDE7A Q13946 1/20 0.41
FGFR3 P22607 1/20 0.39
JAK2 O60674 1/20 0.39
KDM5C P41229 1/20 0.39
KDM4C Q9H3R0 1/20 0.39
ALOX15 P16050 1/20 0.38
PAICS P22234 1/20 0.38
KCNH2 Q12809 1/20 0.37
AOC3 Q16853 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3399672 0.82 HRH3 (0.47) HIF1AEPAS1HRH3CXCR4KDM5C
SCHEMBL25798032 0.80 HIF1A (0.51) HIF1AEPAS1HRH3CXCR4PDE7A
SCHEMBL17240067 0.76 HIF1A (0.58) HIF1AEPAS1HRH3CXCR4PDE7A
SCHEMBL13452765 0.72 HRH3 (0.53) HIF1AEPAS1HRH3CXCR4ALOX15
SCHEMBL20160684 0.72 CXCR4 (0.49) HRH3CXCR4KDM5CKDM4CKCNH2
SCHEMBL3314825 0.72 CXCR4 (0.45) HRH3CXCR4MAPK7KDM5CKDM4C
SCHEMBL13187501 0.72 HRH3 (0.53) HIF1AEPAS1HRH3CXCR4ALOX15
SCHEMBL3065752 0.72 CXCR4 (0.45) HRH3CXCR4KDM5CKDM4C
SCHEMBL13764446 0.72 CXCR4 (0.45) HRH3CXCR4MAPK7KDM5CKDM4C
SCHEMBL110617 0.72 HRH3 (0.53) HIF1AEPAS1HRH3CXCR4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2247591-A1 PYRROLO [2, 3-D]PYRIDINES AND USE THEREOF AS TYROSINE KINASE INHIBITORS Novartis AG (CH) 2010-11-10 EP disclosed
WO-2009098236-A1 PYRROLO [2, 3-D] PYRIDINES AND USE THEREOF AS TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 2009-08-13 WO disclosed